SH2B3 and hematopoietic and lymphoid system neoplasm: Mutations in the SH2B3, the gene that encodes for LNK, have been identified in patients with a range of diseases, including blood cancers, autoimmune disorders and heart disease [31,32,33,34,35,36,37,38,39,40].